Insights

Global reach Cepheid operates within a broad healthcare ecosystem and is part of Danaher, enabling access to a wide customer base across central laboratories, hospitals, and near-patient settings. This presents cross-selling opportunities for adjacent diagnostics and life sciences solutions within large enterprise accounts.

Diversified portfolio With a tests portfolio spanning respiratory infections, TB, oncology, women’s health, and healthcare-associated infections, there are multi-disease selling opportunities and the potential to bundle Xpert tests to address comprehensive testing workflows in laboratories and clinics.

Automation advantage GeneXpert systems automate complex PCR workflows, reducing manual load and turnaround times. Target labs and hospitals facing staffing constraints or high workflow complexity as a compelling use case for upgrading to automated molecular diagnostics.

Scale & deployment Cepheid’s solutions are designed for institutions of any size, offering near-patient testing and centralized lab capabilities. Highlight scalable solutions for mid-to-large health systems seeking rapid, accurate diagnostics across multiple departments.

Growth signals Revenue scale and Danaher backing indicate strong financial stability and ongoing investments in diagnostics innovation. Position upcoming product launches, expanded test menus, or international expansion as opportunities to engage procurement and strategy stakeholders.

Similar companies to Cepheid

Cepheid Tech Stack

Cepheid uses 8 technology products and services including Alteryx, IBM Cognos Analytics, iCIMS, and more. Explore Cepheid's tech stack below.

Cepheid's Email Address Formats

Cepheid uses at least 4 email formats:
Cepheid Email FormatsExamplePercentage
First.Last@cepheid.comJohn.Doe@cepheid.com
93%
First@cepheid.comJohn@cepheid.com
4%
FirstLast@cepheid.comJohnDoe@cepheid.com
2%
First-Last@cepheid.comJohn-Doe@cepheid.com
1%

Frequently Asked Questions

What is Cepheid's phone number?

Minus sign iconPlus sign icon
You can contact Cepheid's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cepheid's stock symbol?

Minus sign iconPlus sign icon
Cepheid is a publicly traded company; the company's stock symbol is CPHD.

What is Cepheid's official website and social media links?

Minus sign iconPlus sign icon
Cepheid's official website is cepheid.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Cepheid generate?

Minus sign iconPlus sign icon
As of October 2026, Cepheid's annual revenue is estimated to be $1B - $10B.

What is Cepheid's SIC code and NAICS code?

Minus sign iconPlus sign icon
Cepheid's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cepheid have currently?

Minus sign iconPlus sign icon
As of October 2026, Cepheid has approximately 4.6K employees across 6 continents, including North America, Europe and Asia. Key team members include Chief Information Security Officer: J. T., Chief Compliance Officer: M. N. and Chief Information Officer: R. Q. Explore Cepheid's employee directory with LeadIQ.

What industry does Cepheid belong to?

Minus sign iconPlus sign icon
Cepheid operates in the Biotechnology Research industry.

What technology does Cepheid use?

Minus sign iconPlus sign icon
Cepheid's tech stack includes Alteryx, IBM Cognos Analytics, iCIMS, Microsoft Power Apps, Apache Kafka, PostgreSQL, Constant Contact and Miro.

What is Cepheid's email format?

Minus sign iconPlus sign icon
Cepheid's email format typically follows the pattern of First.Last@cepheid.com. Find more Cepheid email formats with LeadIQ.

How much funding has Cepheid raised to date?

Minus sign iconPlus sign icon
As of October 2026, Cepheid has raised $118M in funding. The last funding round occurred on Nov 22, 2021 for $64M.

When was Cepheid founded?

Minus sign iconPlus sign icon
Cepheid was founded in 1996.
Cepheid logo

Cepheid

Biotechnology ResearchCalifornia, United States1001-5000 Employees

Cepheid is a biotechnology company focused on molecular diagnostics that prioritize speed, accuracy, and flexibility in testing. Its GeneXpert platforms and Xpert assays automate complex manual workflows, enabling institutions of varying sizes to perform high-quality PCR testing.

The company's test portfolio spans respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, healthcare-associated infections, oncology, and human genetics. Based in Sunnyvale, California, Cepheid is part of Danaher, a relationship that broadens access to scientific and technical capabilities.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
CPHD
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1996
Employees
1001-5000

Section iconFunding & Financials

  • $118M

    Cepheid has raised a total of $118M of funding over 7 rounds. Their latest funding round was raised on Nov 22, 2021 in the amount of $64M as a Grant.

  • $1B - $10B

    Cepheid's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.